Business
BNG April 2020 Production Numbers
BNG April 2020 Production Numbers.
About this update from Caspian Sunrise Plc
[{"type":"text","content":"\n \n \n RNS Number : 9084M\n Caspian Sunrise plc\n 14 May 2020\n \n \n \n Caspian Sunrise PLC\n (\"Caspian Sunrise\" or the \"Company\")\n \n BNG April 2020 production numbers\n \n Introduction\n \n The Board of Caspian Sunrise is pleased to announce the April 2020, production numbers from its flagship asset BNG.\n \n April 2020 oil production figures\n \n The total number of barrels produced in April 2020, all from the MJF structure, was 48,678 (March 2020, 40,277) at an average daily rate of 1,623 bopd (March 2020, 1,299), an increase of 25 per cent.\n \n The increase in production reflects the contribution from New Well 153, which as previously announced started producing towards the end of April.\n \n Production to date in May 2020, is approximately 2,000 bopd.\n \n Additionally, once we receive the regulatory clearances required to move the South Yelemes structure to an export licence we expect a further increase in daily production from wells on the South Yelemes structure currently shut in during the licence upgrade process.\n \n Contacts:\n \n Caspian Sunrise PLC\n \n Clive Carver\n Executive Chairman +7 727 375 0202\n \n WH Ireland, Nominated Adviser & Broker\n \n James Joyce +44 (0) 207 220 1666\n James Sinclair-Ford\n \n Qualified person\n \n Mr. Nurlybek Ospanov, a consultant to Caspian Sunrise PLC's who is a member of the Society of Petroleum Engineers (\"SPE\"), has reviewed and approved the technical disclosures in this announcement.\n \n This announcement has been posted to:\n \n www.caspiansunrise.com/investors\n \n \n The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.\n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.\n END\n \n MSCKKQBKCBKKFPD\n ","length":3474,"tagName":"div"}]